XML 60 R45.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2021
Stockholders Equity [Line Items]  
Schedule of share-based compensation expense

Year ended December 31, 

    

2021

    

2020

Employee Awards

$

307,963

$

1,411,442

Consulting Awards

 

 

92,947

$

307,963

$

1,504,389

Schedule of stockholders' equity note, warrants or rights

Weighted-  

Weighted- 

Average

Average

Remaining

Number of

Exercise Price

Contractual 

Aggregate 

    

 Shares

    

per Share

    

Term (in years)

    

Intrinsic Value

Outstanding as of December 31, 2020

7,266,420

$

1.03

5.5

$

167,000

Granted

1,158,000

0.82

  

  

Exercised

 

(394,670)

 

0.52

 

  

 

  

Forfeited or expired

 

(3,126,205)

 

1.04

 

  

 

  

Outstanding as of December 31, 2021

 

4,903,545

 

$

1.11

 

5.3

$

22,000

Exercisable as of December 31, 2021

 

3,893,665

$

1.21

 

5.6

$

4,000

Weighted-

Weighted-

average

average

Remaining

Number of

Exercise Price

Contractual

Aggregate

    

Shares

    

per Share

    

Term (in years)

    

Intrinsic Value

Outstanding as of December 31, 2020

 

100,000

$

1.22

 

2.3

  

Granted

 

 

 

  

 

  

Exercised

 

 

 

  

 

  

Forfeited or expired

 

(40,000)

 

0.61

 

  

 

  

Outstanding and exercisable as of December 31, 2021

60,000

$

1.55

 

2.3

$

    

    

    

Weighted- 

    

Weighted-

average 

average 

Remaining 

Number of 

Exercise Price 

Contractual

Aggregate 

Shares

per Share

Term (in years)

Intrinsic Value

Outstanding as of December 31, 2019

 

8,473,214

$

0.64

 

  

 

  

Granted

 

7,143,011

 

0.42

 

  

 

  

Exercised

 

(1,131,000)

 

0.40

 

  

 

  

Expired

 

(7,064,214)

 

0.63

 

  

 

  

Outstanding as of December 31, 2020

 

7,421,011

 

0.46

 

2.0

 

$

478,925

Granted

 

1,868,518

 

0.56

 

  

 

  

Exercised

 

 

 

  

 

  

Expired

 

(1,204,000)

 

0.65

 

  

 

  

Outstanding and exercisable as of December 31, 2021

8,085,529

$

0.58

 

2.8

$

Employee Awards [Member]  
Stockholders Equity [Line Items]  
Schedule of defined benefit plan, assumptions

Year ended December 31, 

 

    

2021

    

2020

 

Exercise price

$

0.22 - 0.95

$

0.31 - 0.67

Stock price on date of grant

$

0.22 - 0.95

$

0.27 - 0.67

Volatility

 

100 - 111

%  

 

111 - 114

%

Risk-free interest rate

 

0.29 - 0.97

%  

 

0.16 - 1.53

%

Expected life (years)

 

3.0

 

3.0

Dividend yield

 

 

Year ended December 31, 

 

    

2021

    

2020

 

Exercise price

$

$

0.61

Stock price, date of valuation

$

$

0.61

Volatility

 

%  

 

101

%

Risk-free interest rate

 

%  

 

1.47

%

Expected life (years)

 

 

1.0

Dividend yield